Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Schilsky
Michael
M
D002614:Chelating Agents / Q000627:therapeutic use; D003300:Copper / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism; D008668:Metallothionein / Q000378:metabolism; D010396:Penicillamine / Q000627:therapeutic use; D014131:Trace Elements / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D015032:Zinc / Q000009:adverse effects / Q000627:therapeutic use*
D002614:Chelating Agents; D014131:Trace Elements; D003300:Copper; D008668:Metallothionein; D010396:Penicillamine; D015032:Zinc